Cardiff Oncology Inc

CRDFNASDAQ · USD
1.21USD0.00 (+3.42%)
145

Cardiff Oncology Inc (CRDF) Straddle

CRDF straddle scan found 7 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 42.5%.

Read more

Trading a CRDF straddle lets you take a pure volatility position on Cardiff Oncology Inc without committing to a direction. Cardiff Oncology Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate CRDF straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on CRDF profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Cardiff Oncology Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the CRDF straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company's TROV-053 is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. The company primarily serves pharmaceutical manufacturers.

The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the CRDF straddle is the cleanest expression of that view. Our scanner prices every CRDF straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a CRDF straddle into a catalyst or short a CRDF straddle to harvest decay, the options straddle setups that matter are all in one place.

Jan 21, 20285.00$3.934792%42.5%$8.93$1.080
Jan 15, 20272.00$0.931082%32.2%$2.93$1.089
Jan 21, 20282.50$1.804792%8.9%$4.30$0.7039
Jan 21, 20287.50$6.834792%7.4%$14.33$0.680
Jan 21, 20282.00$1.504792%1.3%$3.50$0.505
Jan 21, 20281.50$1.154792%1.3%$2.65$0.350
Jan 15, 20271.50$0.781082%0.3%$2.28$0.7334

As of September 29, 2026

Find the right straddle before volatility moves

Track CRDF straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial